{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-028078","form_type":"8-K","ticker":"AVTR","cik":"0001722482","company_name":"Avantor, Inc.","filed_at":"2026-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.808586+00:00","generated_at":"2026-05-15T02:18:50.297781+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Avantor Q1 net sales flat YoY; GAAP EPS $0.06, adj. EPS $0.17; reaffirms FY 2026 guidance","bullets":["Net sales $1,581M flat YoY; organic sales down 4.1% due to FX headwind of 4.1%.","GAAP net income $43.3M ($0.06 EPS) vs $64.5M; adjusted net income $114.0M ($0.17 adj. EPS).","Adjusted EBITDA $219.4M (13.9% margin); adjusted operating income $190.6M (12.1% margin).","VWR Distribution segment organic sales -4.8%; Bioscience & Medtech organic sales -2.0%.","Operating cash flow $58.7M; free cash flow $25.2M; adjusted net leverage 3.3x."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-028078","json":"https://secwatch.observer/filing/0001628280-26-028078.json","markdown":"https://secwatch.observer/filing/0001628280-26-028078.md","text":"https://secwatch.observer/filing/0001628280-26-028078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1722482/000162828026028078/0001628280-26-028078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1722482/000162828026028078/avtr-20260429.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T02:18:50.297781+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4bc6e28a230a7d7a7bc28475b0f1b64fbad69741","claim":"Avantor, Inc. reported first fiscal quarter ended March 31, 2026 results: revenue $1,581.4 million, net income $43.3 million, EPS $0.06. Guidance reaffirmed.","evidence_excerpt":"Act of 1933, except as expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Avantor® Reports First Quarter 2026 Results • Net sales of $1,581 million • Net income of $43 million; Adjusted EBITDA of $219 million • Diluted GAAP EPS of $0.06; adjusted EPS of $0.17 • Operating cash flow of $59 million; free cash flow of $25","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1722482/000162828026028078/0001628280-26-028078-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first fiscal quarter ended March 31, 2026"},{"label":"Revenue","value":"$1,581.4 million"},{"label":"Net income","value":"$43.3 million"},{"label":"EPS","value":"$0.06"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}